Beta Adrenergics

Beta adrenergic drugs change sympathetic signalling by acting at beta receptors. Beta-1 stimulation primarily increases heart rate, atrioventricular conduction, myocardial contractility, and renin release. Beta-2 stimulation relaxes bronchial smooth muscle and can also produce uterine relaxation, tremor, intracellular potassium shift, and increased blood glucose. Salbutamol is used therapeutically because its beta-2 effect opens narrowed airways. It activates beta-2 receptors on airway smooth muscle, increases intracellular cyclic adenosine monophosphate, and relaxes the muscle surrounding the bronchi. The same receptor activity that improves airflow can produce tremor, palpitations, tachycardia, hypokalaemia, or hyperglycaemia when enough drug reaches the circulation. The word beta is not enough to guide a safe decision. Identify whether the drug stimulates or blocks the receptor, which receptor is most clinically relevant, and whether the patient’s response shows benefit or toxicity. A beta blocker, particularly a non-selective agent such as propranolol, can oppose beta-2 bronchodilation and make wheezing harder to treat.